Breaking News Instant updates and real-time market news.

ALPMY

Astellas Pharma

$15.09

-0.12 (-0.79%)

17:30
10/09/16
10/09
17:30
10/09/16
17:30

Astellas Pharma reports data on Xtandi in prostate cancer

Astellas Pharma announced the presentation of new data that "reaffirms the role" of XTANDI in extending time to prostate specific antigen progression in men with advanced prostate cancer. Data from a study examining the efficacy and safety of enzalutamide versus placebo in 409 Asian patients from China, South Korea, Taiwan and Hong Kong with asymptomatic/mildly symptomatic progressive advanced prostate cancer following androgen deprivation therapy found that enzalutamide significantly improved time to PSA progression, compared with placebo -- 7.46 months vs 2.86 months. Secondary end points included overall survival, defined as time from randomisation to death from any cause, and radiographic progression free survival. Although the median overall survival was not yet reached at the time of the data cut-off in either treatment arm, enzalutamide significantly reduced the risk of death. At data cut-off, enzalutamide significantly reduced the risk of rPFS events with 19.6% of patients receiving enzalutamide and 36% of patients in the placebo arm experiencing a rPFS event. While slightly more patients treated with enzalutamide reported at least one treatment-emergent adverse event, enzalutamide was generally well tolerated in the trial.

ALPMY Astellas Pharma
$15.09

-0.12 (-0.79%)

07/07/16
UBSW
07/07/16
INITIATION
UBSW
Buy
Astellas Pharma initiated with a Buy at UBS
UBS analyst Atsushi Seki started Astellas Pharma with a Buy rating and Y1,900 price target.

TODAY'S FREE FLY STORIES

PKE

Park Electrochemical

$18.66

0.02 (0.11%)

06:31
06/28/17
06/28
06:31
06/28/17
06:31
Earnings
Park Electrochemical reports Q1 EPS before items 12c, consensus 13c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

CBI

CB&I

$20.02

5.62 (39.03%)

06:28
06/28/17
06/28
06:28
06/28/17
06:28
Recommendations
CB&I analyst commentary  »

Court ruling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOSBF

Toshiba, also use TOSYY

$2.60

-0.09 (-3.35%)

, TOSYY

Toshiba, also use TOSBF

$15.67

-0.24 (-1.51%)

06:28
06/28/17
06/28
06:28
06/28/17
06:28
Periodicals
Toshiba to file $1B lawsuit against Western Digital, Reuters reports »

Toshiba (TOSBF, TOSYY)…

TOSBF

Toshiba, also use TOSYY

$2.60

-0.09 (-3.35%)

TOSYY

Toshiba, also use TOSBF

$15.67

-0.24 (-1.51%)

WDC

Western Digital

$91.85

-0.81 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOP

Koppers Holdings

$34.00

-0.7 (-2.02%)

06:22
06/28/17
06/28
06:22
06/28/17
06:22
Upgrade
Koppers Holdings rating change  »

Koppers Holdings upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRB

H&R Block

$31.34

0.02 (0.06%)

06:18
06/28/17
06/28
06:18
06/28/17
06:18
Conference/Events
H&R Block management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

PFPT

Proofpoint

$84.48

-1.3 (-1.52%)

, SYMC

Symantec

$28.11

-0.75 (-2.60%)

06:18
06/28/17
06/28
06:18
06/28/17
06:18
Recommendations
Proofpoint, Symantec analyst commentary  »

Piper highlights…

PFPT

Proofpoint

$84.48

-1.3 (-1.52%)

SYMC

Symantec

$28.11

-0.75 (-2.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLI

Houlihan Lokey

$34.48

0.1 (0.29%)

06:18
06/28/17
06/28
06:18
06/28/17
06:18
Conference/Events
Houlihan Lokey management to meet with JMP Securities »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

HAL

Halliburton

$41.53

-0.17 (-0.41%)

06:17
06/28/17
06/28
06:17
06/28/17
06:17
Conference/Events
Halliburton management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

  • 24

    Jul

FIVE

Five Below

$47.79

-0.545 (-1.13%)

06:16
06/28/17
06/28
06:16
06/28/17
06:16
Conference/Events
Five Below management to meet with Loop Capital »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

AABA

Altaba

$53.64

-0.67 (-1.23%)

, BABA

Alibaba

$141.53

-1.2 (-0.84%)

06:15
06/28/17
06/28
06:15
06/28/17
06:15
Initiation
Altaba, Alibaba, Yahoo Japan initiated  »

Altaba initiated with an…

AABA

Altaba

$53.64

-0.67 (-1.23%)

BABA

Alibaba

$141.53

-1.2 (-0.84%)

YAHOY

Yahoo Japan

$8.77

0.05 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

GIL

Gildan Activewear

$31.44

-0.3 (-0.95%)

06:08
06/28/17
06/28
06:08
06/28/17
06:08
Upgrade
Gildan Activewear rating change  »

Gildan Activewear…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOV

Government Properties

$21.90

-0.425 (-1.90%)

06:07
06/28/17
06/28
06:07
06/28/17
06:07
Syndicate
Government Properties files to sell 25M shares of common stock »

The joint bookrunning…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRNT

Ceragon Networks

06:06
06/28/17
06/28
06:06
06/28/17
06:06
Hot Stocks
Ceragon Networks receives new orders from Tier 1 South Cone operator »

Ceragon Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jul

  • 13

    Jul

FDC

First Data

$18.53

-0.18 (-0.96%)

06:06
06/28/17
06/28
06:06
06/28/17
06:06
Downgrade
First Data rating change  »

First Data downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

EGOV

NIC Inc.

$19.00

-0.55 (-2.81%)

06:05
06/28/17
06/28
06:05
06/28/17
06:05
Initiation
NIC Inc. initiated  »

NIC Inc. initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FPO

First Potomac

, GOV

Government Properties

$21.90

-0.425 (-1.90%)

06:02
06/28/17
06/28
06:02
06/28/17
06:02
Hot Stocks
First Potomac to be acquired by Government Properties in $1.4B deal »

First Potomac Realty…

FPO

First Potomac

GOV

Government Properties

$21.90

-0.425 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

06:01
06/28/17
06/28
06:01
06/28/17
06:01
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FPO

First Potomac

, GOV

Government Properties

$21.90

-0.425 (-1.90%)

06:00
06/28/17
06/28
06:00
06/28/17
06:00
Hot Stocks
Breaking Hot Stocks news story on First Potomac, Government Properties »

First Potomac to be…

FPO

First Potomac

GOV

Government Properties

$21.90

-0.425 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$21.13

-0.18 (-0.84%)

06:00
06/28/17
06/28
06:00
06/28/17
06:00
Syndicate
Canada Goose 12.5M share Secondary priced at $20.75 »

CIBC, Credit Suisse,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

RGEN

Repligen

$43.25

-2.09 (-4.61%)

05:59
06/28/17
06/28
05:59
06/28/17
05:59
Syndicate
Repligen 2.807M share Spot Secondary priced at $42.75 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

GDX

Market Vector Gold Miners

$22.26

-0.3 (-1.33%)

05:59
06/28/17
06/28
05:59
06/28/17
05:59
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$118.81

0.45 (0.38%)

05:59
06/28/17
06/28
05:59
06/28/17
05:59
Technical Analysis
SPDR Gold Trust: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUGT

Direxion Gold Miners Bull

$31.50

-1.23 (-3.76%)

05:58
06/28/17
06/28
05:58
06/28/17
05:58
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYG

Tortoise Energy

$29.13

-0.14 (-0.48%)

05:58
06/28/17
06/28
05:58
06/28/17
05:58
Upgrade
Tortoise Energy rating change  »

Tortoise Energy upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$18.89

-0.46 (-2.38%)

05:58
06/28/17
06/28
05:58
06/28/17
05:58
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.